Abstract:Ethnopharmacological relevance: 1-Deoxynojirimycin (DNJ), the major alkaloid in Morus alba L., is the main effective constituent in "Mulberry twig Alkaloids Tablets" launched in China in 2020. Prediabetes, characterized by insulin resistance, is regarded as the key period for reversing Type 2 diabetes mellitus (T2DM) through lifestyle intervention and glucose-lowering drugs. Besides the excellent activity as an α-glucosidase inhibitor, DNJ also improves insulin sensitivity in T2DM murine models, yet the mechanism is still unclear. Besides, the pharmaceutical effect of DNJ on prediabetes is also undocumented. Aim of the study: The aim of this study was to investigate the pharmaceutical effect of DNJ on high-fat and streptozotocin (STZ)-induced prediabetes mice, and to elucidate the mechanism of insulin resistance ameliorated by DNJ. Materials and methods: Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed to detect blood glucose level and insulin sensitivity in mice. The levels of circulating lipopolysaccharide (LPS), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) in the plasma of mice were measured by limulus reagent and enzyme-linked immunosorbent assay (ELISA), respectively. Next-generation sequencing (NGS) and intestinal microbiota sequencing were used to screen the alterations in the transcriptome of liver tissues and to assess the differences in intestinal flora composition, respectively. Expression of cytokine signaling pathway inhibitor 3 (SOCS3), insulin receptor substrate (IRS1), p-IRS1 (Tyr896), occludin, and toll like receptor 4 (TLR4)/NF-κB signaling pathway were confirmed by western blotting. Results: Our study revealed that DNJ decreased the blood glucose level and improve insulin sensitivity in prediabetic mice. DNJ significantly reduced the relative risk of T2DM in prediabetic mice by approximately 83.7%. Mechanistically, DNJ treatment suppressed the circulating levels of LPS, IL-6, and TNF-α in plasma and decreased the inflammatory infiltration in liver and colon tissues. DNJ-treatment increased the abundance of Akkermansia, Bifidobacterium, and Lactobacillus, and decreased the abundance of Enterococcaceae and Lachnospiraceae. Moreover, DNJ suppressed the expression of SOCS3 and the activity of TLR4/NF-κB signaling pathway, meanwhile improving the expression of occludin and the ratio of p-IRS1 (Tyr896)/IRS1. Conclusions: DNJ effectively ameliorates glucose and lipid metabolism in prediabetic mice, and decreased the relative risk of progression into T2DM from prediabetes. The suppressed immune responses play essential roles in the improvement of insulin resistance by DNJ treatment. In conclusion, DNJ from Morus alba L. is a promising alternative agent in T2DM prevention.

Research progress in effect of 1-deoxynojirimycin on glucolipid metabolism

Research Progress of 1-Deoxynojirimycin

[Recent research advances of 1-deoxynojirimycin and its derivatives].

Research Progress in Origin and Synthesis of 1-Deoxynojirimycin

1-Deoxynojirimycin and its Derivatives: A Mini Review of the Literature

Review of the research on 1-deoxynojirimycin(dnj) in mulberry

1-Deoxynojirimycin: Occurrence, Extraction, Chemistry, Oral Pharmacokinetics, Biological Activities and In Silico Target Fishing

1-Deoxnojirinicin and its Derivatives: A Mini Review of the Literature

Verification and applications of 1-deoxynojirimycin biosynthesis: Recent advances and future prospects

Progress in Pharmacological Function and Pharmacokinetic Studies on Mulberry 1-Deoxynojirimycin and Its Derivatives

Effect of 1-Deoxynojirimycin on Lipid Metabolism in Normal Mice and Preliminary Exploration of the Underlying Mechanism

An Overview of Therapeutic Potential of N-alkylated 1-Deoxynojirimycin Congeners.

Effect and Mechanism of 1-Deoxynojirimycin on Lipid Metabolism in Obese Mice

Effect of 1-Deoxynojirimycin Isolated from Mulberry Leaves on Glucose Metabolism and Gut Microbiota in a Streptozotocin-Induced Diabetic Mouse Model

Effect of 1-Deoxynojirimycin on insulin resistance in prediabetic mice based on next-generation sequencing and intestinal microbiota study

1-Deoxynojirimycin modulates glucose homeostasis by regulating the combination of IR-GlUT4 and ADIPO-GLUT4 pathways in 3T3-L1 adipocytes

1-Deoxynojirimycin Improves High Fat Diet-Induced Nonalcoholic Steatohepatitis by Restoring Gut Dysbiosis.

Effect Of 1-Deoxynojirirnycin Isolated From Mulberry Leaves On Glucose Metabolism And Gut Microbiota In A Streptozotocin-Induced Diabetic Mouse Model

THE RESEARCH PROGRESS ON BIOLOGICAL ACTIVITIES OF MOMORDICOSIDES

Synthesis of N-Glycyl-2,3,4,6-tetra-O-benzyl-1,5-dideoxy-1,5- Imino-D-glucitol

Evaluation of the anti-hyperglycemic effect and safety of microorganism 1-deoxynojirimycin